Official Journal Health Science of Prince of Songkla University

  • Home
  • Search
  • Current
  • Archives
  • Announcements
  • Guide for Authors
  • Publication Ethics
  • Editorial Board
  • Submit
  • About
  • Contact
  • Online-first Articles
  • EVENTS
  • Review Process
Home > Online-first > Leelasirivilat

Factors Associated with Complete Abortion in Elective Medically Induced Abortion of Pregnancy at A Tertiary Care Hospital in Southern Thailand

Ruenrudee Leelasirivilat, Nathapol Sirimusika, Sorawat Sangkeaw

Abstract

Objective: To identify the factors associated with successful complete abortion in women undergoing elective medically induced abortion of pregnancy at gestational age ≤24 weeks at a tertiary care hospital in Southern Thailand.
Material and Methods: This retrospective cohort study reviewed medical records from January 2017 to June 2024 of women with unintended pregnancies at GA ≤24 weeks who underwent medical abortion using mifepristone and misoprostol. Multivariable logistic regression identified factors associated with abortion success and complications.
Results: Complete abortion was significantly higher among women with gestational age ≤12 weeks (59.5%, 251/378) compared to those >12 weeks (40.5%, 171/306) (p-value 0.006). Overall, among 684 cases, complete abortion was achieved in 422 (61.7%). Surgical intervention was required in 35.2%, sponge forceps uterine evacuation in 2.9%, and subtotal hysterectomy in 0.1%. Gestational age beyond 12 weeks was associated with an increased risk of incomplete abortion (adjusted odds ratio [OR] 1.61, 95% confidence interval [CI] 1.17–2.21).
Conclusion: Gestational ages ≤12 weeks had higher complete abortion rates. Early access to abortion services may reduce complications and improve success rates.

 Keywords

medical abortion; mifepristone; misoprostol; repeated abortion; unintended pregnancy

 Full Text:

PDF

References

Centers for Disease Control and Prevention. Unintended Pregnancy [monograph on the Internet]. Atlanta: CDC; 2024 [cited 2025 Jul 16]. Available from: https://www.cdc.gov/reproductive-health/hcp/unintended-pregnancy/index.html

Singh S, Shekhar C, Acharya R, Moore AM, Stillman M, Pradhan MR, et al. The incidence of abortion and unintended pregnancy in India, 2015. Lancet Glob Health 2018;6:20.

Jones RK. An estimate of lifetime incidence of abortion in the United States using the 2021–2022 abortion patient survey. Contraception 2024;135:110445.

Sedgh G, Bearak J, Singh S, Bankole A, Popinchalk A, Ganatra B, et al. Abortion incidence between 1990 and 2014: Global, regional, and subregional levels and trends. Lancet. 2016;388:258–67.

Guttmacher Institute. Unsafe abortion. Abortion in Asia [monograph on the Internet]. New York: Guttmacher Institute; 2018 [cited 2024 Aug 19]. Available from: https://www.guttmacher.org/sites/default/files/factsheet/ib_aww-asia.pdf

Royal Thai College of Obstetricians and Gynecologists. Clinical Practice Guidelines Induced Abortion [monograph on the Internet]. Bangkok: Royal Thai College of Obstetricians and Gynecologists; 2023. [cited 2024 Aug 19]. Available from: https://www.rtcog.or.th/files/1687830531_202b237fd7ad5bdafb0c.pdf

Criminal Code Amendment Act (No. 28), B.E. 2564 (2021) [monograph on the Internet]. Bangkok: The Secretariat of The Cabinet of Thailand; 2021 [cited 2024 Aug 19]. Available from: https://www.ratchakitcha.soc.go.th/DATA/PDF/2564/A/010/T_0001.PDF

Barghazan SH, Hadian M, Rezapour A, Nassiri S. Comparison of the clinical efficacy of surgical versus medical method for first trimester pregnancy abortion in Iran: A quasi-experimental research. J Educ Health Promot 2023;12:132.

Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM, et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med 2005;353:761–9.

Jones RK, Jerman J. Abortion incidence and service availability in the United States, 2014. Perspect Sex Reprod Health 2017;49:17-27.

Shah D, Rijal P, Thakur A, Rai R. Mifepristone and misoprostol vs misoprostol alone in second trimester abortion of pregnancy. JNMA J Nepal Med Assoc 2018;56:856-60.

Sudsai W, Suwanrath C, Choobun T. Medical abortion at gestational age ≤24 weeks at Songklanagarind Hospital. Thai J Obstet Gynaecol 2022;30:198–206.

Hendriks E, MacNaughton H, MacKenzie MC. First Trimester Bleeding: Evaluation and Management. Am Fam Physician 2019;99:166-74.

Abortion [homepage on the Internet]. Chiang Mai: Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University; 2010 [cited 2024 Aug 19]. Available from: https://w1.med.cmu.ac.th/obgyn/lecturestopics/extern-intern/1397/

Jackson HM, Rendall MS. Lifetime abortion incidence when abortion care is covered by Medicaid: Maryland versus five comparison states. Health Serv Res 2024;59:e14358.

Jones RK, Kirstein M, Philbin J. Abortion incidence and service availability in the United States, 2020. Perspect Sex Reprod Health 2022;54:128–41.

Sexual and Reproductive Health and Research (SRH). Abortion care guideline: Chapter 1, Introduction [monograph on the Internet]. Geneva: WHO; 2022 [cited 2025 Jul 16]. Available from: https://www.ncbi.nlm.nih.gov/books/NBK578948

American College of Obstetricians and Gynecologists' Committee on Practice Bulletins—Gynecology, Society of Family Planning. Medication abortion up to 70 days of gestation: acog practice bulletin, number 225. Obstet Gynecol 2020;136:e31-47.

Mentula M, Heikinheimo O. Risk factors of surgical evacuation following second-trimester medical abortion of pregnancy. Contraception 2012;86:141-6.

World Health Organization. Adolescent pregnancy [monograph on the Internet]. Geneva: WHO; 2024 [cited 2024 Sep 26]. Available from: https://www.who.int/news-room/fact-sheets/detail/adolescent-pregnancy

Wiebe E. Adolescent girls undergoing medical abortion have lower risk of hemorrhage, incomplete evacuation or surgical evacuation than women above 18 years old. Evid Based Med 2012;17:18–9.

Niinimäki M, Suhonen S, Mentula M, Hemminki E, Heikinheimo O, Gissler M. Comparison of rates of adverse events in adolescent and adult women undergoing medical abortion: Population register-based study. BMJ 2011;342:d2111.

Shannon C, Wiebe E, Jacot F, Guilbert E, Dunn S, Sheldon WR, et al. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial. BJOG 2006;113:621-8.

Renner RM, de Guzman A, Brahmi D. Abortion care for adolescent and young women. Int J Gynaecol Obstet 2014;126:1–7.

DOI: http://dx.doi.org/10.31584/jhsmr.20261390

Refbacks

  • There are currently no refbacks.
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

SUBMIT A PAPER

JHSMR accepts online submission through

AHR-iCON 2026

About The Authors

Ruenrudee Leelasirivilat
Department of Obstetrics and Gynecology, Hatyai Hospital, Hat Yai, Songkhla 90110,
Thailand

Nathapol Sirimusika
Department of Obstetrics and Gynecology, Hatyai Hospital, Hat Yai, Songkhla 90110,

Sorawat Sangkeaw
Department of Obstetrics and Gynecology, Hatyai Hospital, Hat Yai, Songkhla 90110,
Thailand

Article Tools
Abstract
Print this article
Indexing metadata
How to cite item
Email this article (Login required)
Email the author (Login required)

Journal Metrics

2023 (June)
Acceptance rate: 23.6%
2024 (June)
Acceptance rate: 19%
2025 (June)
Acceptance rate: 23%



Submission to final decision
74 days

Acceptance to publication
40 days

0.7
2025
CiteScore
 
32nd percentile
Q 3

Supported by

 

JHSMR now Indexed in








Image result for crossref





PSUMJ Homepage

Keywords COVID-19 SARS-CoV-2 Thailand Vietnam adolescent children computed tomography depression diabetes diabetes mellitus elderly knowledge mental health mortality older adults prevalence quality of life reliability risk factors treatment validity
Journal Content

Browse
  • By Issue
  • By Author
  • By Title
Font Size

Open Journal Systems